MedTrace Logo

Ocular-vestibular Biomarker Identification for ADHD

NCT04504890 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2020-10-23

No results posted yet for this study

Summary

This study intends to establish a relationship between oculovestibular eye tracking measures, measures of ADHD, and medication prescribed for ADHD.

Conditions

  • ADHD - Combined Type
  • ADHD
  • ADHD Predominantly Inattentive Type
  • ADHD, Predominantly Hyperactive - Impulsive

Interventions

DEVICE

EYE-SYNC

Nystagmograph used to measure eye movement

Sponsors & Collaborators

  • Sutter Health

    collaborator OTHER

  • Sync-Think, Inc.

    lead INDUSTRY

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-16
Primary Completion
2021-08-05
Completion
2021-10-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04504890 on ClinicalTrials.gov